144 related articles for article (PubMed ID: 27275226)
1. Detection of BCR/ABL Translocation in Bone Marrow Derived Mesenchymal Stem Cells in Egyptian CML Patients.
Gaafar TM; Raafat II; Aly AA; Mohamed NA; Farid RJ; Saad NE; El-Hawary R; Mostafaa N; Ahmed MM
Open Access Maced J Med Sci; 2015 Jun; 3(2):231-6. PubMed ID: 27275226
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow derived mesenchymal stem cells from chronic myeloid leukemia t(9;22) patients are devoid of Philadelphia chromosome and support cord blood stem cell expansion.
Jootar S; Pornprasertsud N; Petvises S; Rerkamnuaychoke B; Disthabanchong S; Pakakasama S; Ungkanont A; Hongeng S
Leuk Res; 2006 Dec; 30(12):1493-8. PubMed ID: 16839603
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem cells from patients with chronic myeloid leukemia do not express BCR-ABL and have absence of chimerism after allogeneic bone marrow transplant.
Carrara RC; Orellana MD; Fontes AM; Palma PV; Kashima S; Mendes MR; Coutinho MA; Voltarelli JC; Covas DT
Braz J Med Biol Res; 2007 Jan; 40(1):57-67. PubMed ID: 17224997
[TBL] [Abstract][Full Text] [Related]
4. Assessment of bone marrow mesenchymal stem cell biological characteristics and support hemotopoiesis function in patients with chronic myeloid leukemia.
Zhao Z; Tang X; You Y; Li W; Liu F; Zou P
Leuk Res; 2006 Aug; 30(8):993-1003. PubMed ID: 16448696
[TBL] [Abstract][Full Text] [Related]
5. Chronic myelogenous leukemia: molecular and cellular aspects.
Pasternak G; Hochhaus A; Schultheis B; Hehlmann R
J Cancer Res Clin Oncol; 1998; 124(12):643-60. PubMed ID: 9879825
[TBL] [Abstract][Full Text] [Related]
6. [Isolation and identification of chronic myelogenous leukemia bone marrow mesenchymal stem cells and their functional characteristics].
Zhao ZG; Tang XQ; Li J; Shi MX; Zou P
Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(29):2054-7. PubMed ID: 16313801
[TBL] [Abstract][Full Text] [Related]
7. Megakaryocytes carry the fused bcr-abl gene in chronic myeloid leukaemia: a fluorescence in situ hybridization analysis from bone marrow biopsies.
Nolte M; Werner M; Ewig M; von Wasielewski R; Link H; Diedrich H; Georgii A
Virchows Arch; 1996 Mar; 427(6):561-5. PubMed ID: 8605566
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase-9 was involved in the immuno-modulatory defect of mesenchymal stem cell from chronic myeloid leukemia patients.
Zhu XS; Shi W; An GY; Zhang HM; Song YG; Li YB
Chin Med J (Engl); 2011 Aug; 124(16):2423-30. PubMed ID: 21933581
[TBL] [Abstract][Full Text] [Related]
9. Leukemia cell lines: in vitro models for the study of Philadelphia chromosome-positive leukemia.
Drexler HG; MacLeod RA; Uphoff CC
Leuk Res; 1999 Mar; 23(3):207-15. PubMed ID: 10071072
[TBL] [Abstract][Full Text] [Related]
10. [Progress in laboratory medicine in chronic myeloid leukemia].
Miura A
Rinsho Byori; 1998 Dec; 46(12):1226-31. PubMed ID: 9916508
[TBL] [Abstract][Full Text] [Related]
11. Chronic Myeloid Leukemia (CML) Mouse Model in Translational Research.
Peng C; Li S
Methods Mol Biol; 2016; 1438():225-43. PubMed ID: 27150093
[TBL] [Abstract][Full Text] [Related]
12. [Detection of phosphotyrosine in chronic myeloid leukemia cells with PY20 antibody and its clinical applications].
Tian J; Cheng H; Xu KL; Pan XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):1056-60. PubMed ID: 19698259
[TBL] [Abstract][Full Text] [Related]
13. The characteristics and immunoregulatory functions of regulatory dendritic cells induced by mesenchymal stem cells derived from bone marrow of patient with chronic myeloid leukaemia.
Zhao ZG; Xu W; Sun L; Li WM; Li QB; Zou P
Eur J Cancer; 2012 Aug; 48(12):1884-95. PubMed ID: 22129888
[TBL] [Abstract][Full Text] [Related]
14. Reduced efficacy of mesenchymal stromal cells in preventing graft-versus-host disease in an in vivo model of haploidentical bone marrow transplant with leukemia.
Oviedo A; Yañez R; Colmenero I; Aldea M; Rubio A; Bueren JA; Lamana ML
Cell Transplant; 2013; 22(8):1381-94. PubMed ID: 23044223
[TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of cytogenetic monitoring in chronic myeloid leukemia].
Pan CY; Xu N; He BL; Cao R; Liao LB; Yin CX; Lan YQ; Lu ZY; Huang JX; Sun J; Feng R; Liu QF; Liu XL
Zhonghua Xue Ye Xue Za Zhi; 2017 Feb; 38(2):112-117. PubMed ID: 28279034
[No Abstract] [Full Text] [Related]
16. Bone marrow mesenchymal stromal cell (MSC) gene profiling in chronic myeloid leukemia (CML) patients at diagnosis and in deep molecular response induced by tyrosine kinase inhibitors (TKIs).
Aggoune D; Sorel N; Bonnet ML; Goujon JM; Tarte K; Hérault O; Domenech J; Réa D; Legros L; Johnson-Ansa H; Rousselot P; Cayssials E; Guerci-Bresler A; Bennaceur-Griscelli A; Chomel JC; Turhan AG
Leuk Res; 2017 Sep; 60():94-102. PubMed ID: 28772207
[TBL] [Abstract][Full Text] [Related]
17. Chronic myeloid leukemia stem cells.
Jamieson CH
Hematology Am Soc Hematol Educ Program; 2008; ():436-42. PubMed ID: 19074122
[TBL] [Abstract][Full Text] [Related]
18. [Detection of BCR/ABL fusion gene by fluorescence in situ hybridization and its clinical application].
Zhou RL; Mo YX; Lan M; Lin JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Oct; 19(5):1283-8. PubMed ID: 22040989
[TBL] [Abstract][Full Text] [Related]
19. Review of clinical, cytogenetic, and molecular aspects of Ph-negative CML.
van der Plas DC; Grosveld G; Hagemeijer A
Cancer Genet Cytogenet; 1991 Apr; 52(2):143-56. PubMed ID: 2021916
[TBL] [Abstract][Full Text] [Related]
20. BCR/ABL oncogene-induced PI3K signaling pathway leads to chronic myeloid leukemia pathogenesis by impairing immuno-modulatory function of hemangioblasts.
Li Q; Wu Y; Fang S; Wang L; Qi H; Zhang Y; Zhang J; Li W
Cancer Gene Ther; 2015 May; 22(5):227-37. PubMed ID: 25837664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
